Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes

The metabolic dealkylation of nine nitrosodialkylamines, including five symmetrical (nitrosodimethylamine, nitroso-diethylamine, nitrosodipropylamine, nitrosodibutylamine and nitrosodiamylamine) and four asymmetrical nitro-sodialkylamines (nitrosomethylethylamine, nitrosomethyl-propylamine, nitrosom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carcinogenesis (New York) 1996-09, Vol.17 (9), p.2029-2034
Hauptverfasser: Bellec, Gwénaëlle, Dréano, Yvonne, Lozach, Patrick, Ménez, Jean François, Berthou, François
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2034
container_issue 9
container_start_page 2029
container_title Carcinogenesis (New York)
container_volume 17
creator Bellec, Gwénaëlle
Dréano, Yvonne
Lozach, Patrick
Ménez, Jean François
Berthou, François
description The metabolic dealkylation of nine nitrosodialkylamines, including five symmetrical (nitrosodimethylamine, nitroso-diethylamine, nitrosodipropylamine, nitrosodibutylamine and nitrosodiamylamine) and four asymmetrical nitro-sodialkylamines (nitrosomethylethylamine, nitrosomethyl-propylamine, nitrosomethylbutylamine and nitrosomethyl-amylamine), was investigated in 14 samples of human liver microsomes. All these nitrosodialkylamines were dealkylated to aldehydes that were separated by reversed phase HPLC and UV detected as dinitrophenylhydrazones. As the length of the alkyl chain increased from methyl to pentyl, dealkylation of symmetrical nitrosodialkylamines became less efficiently catalyzed by cytochrome P450. Conversely, oxidation of the methyl moiety of asymmetrical nitrosomethylalkylamines increased with the size of the alkyl moiety, while dealkylation of the longer alkyl group decreased. N-Dealkylase activities were significantly correlated with P450 activities measured in human liver micro-somes. These catalytic activities involve CYP2A6 (coumarin 7-hydroxylation), CYP2C (mephenytoin 4-hydroxylation and tolbutamide hydroxylation), CYP2D6 (dextromethor-phan O-demethylation), CYP2E1 (chlorzoxazone and p-nitrophenol hydroxylation) and CYP3A4 (nifedipine oxidation). By using 10 heterologously expressed P450s, it was shown that nitrosodimethylamine was mainly demethylated by CYP2E1. However, such enzyme specificity was lost with increasing size of the alkyl group. Therefore, the chain length of the alkyl group of nitrosodialkylamines determined the P450 involved in its oxidation. All these results emphasize that the catalytic site of P450 2E1 has a geometric configuration such that only small molecules like nitrosodimethylamine fit favorably within the putative active site of the enzyme. Furthermore, there is good evidence that P450s other than P450 2E1, such as P450 2A6, 2C8/2C9/2C19 and 3A4, are involved in the metabolism of nitrosodialkylamines bearing bulky alkyl chains.
doi_str_mv 10.1093/carcin/17.9.2029
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15827087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15827087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-3620b218927d47001e34e57eea035afe8026a9d8bcac11b9e9ee2567c264c02c3</originalsourceid><addsrcrecordid>eNo9kEFP3DAQhS1URLfAnUslH6resoztOI6P1UJLJbRwAAlxsRxnIgxxTO0sYv99s8pqTyPN-97ozSPkgsGSgRaXzibnh0umlnrJgesjsmBlBQVnNXwhC2ClKIQQ5VfyLedXAFYJqU_ISV3zUgq2IGa1HaN7STEgvS8l0ICjbWLvHW3R9m_b3o4-DjR2dPAD0nUx-DHFHFs_q2HaZtps6csm2IH2_gMTDd7tmID5jBx3ts94vp-n5PH39cPqpri9-_N39eu2cELzsRAVh2YKrblqSzXlRFGiVIgWhLQd1sArq9u6cdYx1mjUiFxWyvGqdMCdOCU_57vvKf7bYB5N8Nlh39sB4yYbJmuuoFYTCDO4S5gTduY9-WDT1jAwu07N3Klhymiz63SyfN_f3jQB24NhX-Kk_9jrNjvbd8kOzucDJqa_JIgJK2bM5xE_D7JNb6ZSQklz8_Rs1vL-av18pY0U_wGWJpAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15827087</pqid></control><display><type>article</type><title>Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Bellec, Gwénaëlle ; Dréano, Yvonne ; Lozach, Patrick ; Ménez, Jean François ; Berthou, François</creator><creatorcontrib>Bellec, Gwénaëlle ; Dréano, Yvonne ; Lozach, Patrick ; Ménez, Jean François ; Berthou, François</creatorcontrib><description>The metabolic dealkylation of nine nitrosodialkylamines, including five symmetrical (nitrosodimethylamine, nitroso-diethylamine, nitrosodipropylamine, nitrosodibutylamine and nitrosodiamylamine) and four asymmetrical nitro-sodialkylamines (nitrosomethylethylamine, nitrosomethyl-propylamine, nitrosomethylbutylamine and nitrosomethyl-amylamine), was investigated in 14 samples of human liver microsomes. All these nitrosodialkylamines were dealkylated to aldehydes that were separated by reversed phase HPLC and UV detected as dinitrophenylhydrazones. As the length of the alkyl chain increased from methyl to pentyl, dealkylation of symmetrical nitrosodialkylamines became less efficiently catalyzed by cytochrome P450. Conversely, oxidation of the methyl moiety of asymmetrical nitrosomethylalkylamines increased with the size of the alkyl moiety, while dealkylation of the longer alkyl group decreased. N-Dealkylase activities were significantly correlated with P450 activities measured in human liver micro-somes. These catalytic activities involve CYP2A6 (coumarin 7-hydroxylation), CYP2C (mephenytoin 4-hydroxylation and tolbutamide hydroxylation), CYP2D6 (dextromethor-phan O-demethylation), CYP2E1 (chlorzoxazone and p-nitrophenol hydroxylation) and CYP3A4 (nifedipine oxidation). By using 10 heterologously expressed P450s, it was shown that nitrosodimethylamine was mainly demethylated by CYP2E1. However, such enzyme specificity was lost with increasing size of the alkyl group. Therefore, the chain length of the alkyl group of nitrosodialkylamines determined the P450 involved in its oxidation. All these results emphasize that the catalytic site of P450 2E1 has a geometric configuration such that only small molecules like nitrosodimethylamine fit favorably within the putative active site of the enzyme. Furthermore, there is good evidence that P450s other than P450 2E1, such as P450 2A6, 2C8/2C9/2C19 and 3A4, are involved in the metabolism of nitrosodialkylamines bearing bulky alkyl chains.</description><identifier>ISSN: 0143-3334</identifier><identifier>EISSN: 1460-2180</identifier><identifier>DOI: 10.1093/carcin/17.9.2029</identifier><identifier>PMID: 8824531</identifier><identifier>CODEN: CRNGDP</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Aryl Hydrocarbon Hydroxylases ; Biological and medical sciences ; Biotransformation ; Carcinogenesis, carcinogens and anticarcinogens ; Chemical agents ; Cytochrome P-450 CYP2A6 ; Cytochrome P-450 CYP2C19 ; Cytochrome P-450 CYP2D6 - metabolism ; Cytochrome P-450 CYP2E1 - metabolism ; Cytochrome P-450 CYP3A ; Cytochrome P-450 Enzyme System - metabolism ; Female ; Humans ; Kinetics ; Male ; Medical sciences ; Microsomes, Liver - enzymology ; Mixed Function Oxygenases - metabolism ; Nitrosamines - metabolism ; Recombinant Proteins - metabolism ; Substrate Specificity ; Tumors</subject><ispartof>Carcinogenesis (New York), 1996-09, Vol.17 (9), p.2029-2034</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-3620b218927d47001e34e57eea035afe8026a9d8bcac11b9e9ee2567c264c02c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3218503$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8824531$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bellec, Gwénaëlle</creatorcontrib><creatorcontrib>Dréano, Yvonne</creatorcontrib><creatorcontrib>Lozach, Patrick</creatorcontrib><creatorcontrib>Ménez, Jean François</creatorcontrib><creatorcontrib>Berthou, François</creatorcontrib><title>Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes</title><title>Carcinogenesis (New York)</title><addtitle>Carcinogenesis</addtitle><description>The metabolic dealkylation of nine nitrosodialkylamines, including five symmetrical (nitrosodimethylamine, nitroso-diethylamine, nitrosodipropylamine, nitrosodibutylamine and nitrosodiamylamine) and four asymmetrical nitro-sodialkylamines (nitrosomethylethylamine, nitrosomethyl-propylamine, nitrosomethylbutylamine and nitrosomethyl-amylamine), was investigated in 14 samples of human liver microsomes. All these nitrosodialkylamines were dealkylated to aldehydes that were separated by reversed phase HPLC and UV detected as dinitrophenylhydrazones. As the length of the alkyl chain increased from methyl to pentyl, dealkylation of symmetrical nitrosodialkylamines became less efficiently catalyzed by cytochrome P450. Conversely, oxidation of the methyl moiety of asymmetrical nitrosomethylalkylamines increased with the size of the alkyl moiety, while dealkylation of the longer alkyl group decreased. N-Dealkylase activities were significantly correlated with P450 activities measured in human liver micro-somes. These catalytic activities involve CYP2A6 (coumarin 7-hydroxylation), CYP2C (mephenytoin 4-hydroxylation and tolbutamide hydroxylation), CYP2D6 (dextromethor-phan O-demethylation), CYP2E1 (chlorzoxazone and p-nitrophenol hydroxylation) and CYP3A4 (nifedipine oxidation). By using 10 heterologously expressed P450s, it was shown that nitrosodimethylamine was mainly demethylated by CYP2E1. However, such enzyme specificity was lost with increasing size of the alkyl group. Therefore, the chain length of the alkyl group of nitrosodialkylamines determined the P450 involved in its oxidation. All these results emphasize that the catalytic site of P450 2E1 has a geometric configuration such that only small molecules like nitrosodimethylamine fit favorably within the putative active site of the enzyme. Furthermore, there is good evidence that P450s other than P450 2E1, such as P450 2A6, 2C8/2C9/2C19 and 3A4, are involved in the metabolism of nitrosodialkylamines bearing bulky alkyl chains.</description><subject>Adult</subject><subject>Aryl Hydrocarbon Hydroxylases</subject><subject>Biological and medical sciences</subject><subject>Biotransformation</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Chemical agents</subject><subject>Cytochrome P-450 CYP2A6</subject><subject>Cytochrome P-450 CYP2C19</subject><subject>Cytochrome P-450 CYP2D6 - metabolism</subject><subject>Cytochrome P-450 CYP2E1 - metabolism</subject><subject>Cytochrome P-450 CYP3A</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microsomes, Liver - enzymology</subject><subject>Mixed Function Oxygenases - metabolism</subject><subject>Nitrosamines - metabolism</subject><subject>Recombinant Proteins - metabolism</subject><subject>Substrate Specificity</subject><subject>Tumors</subject><issn>0143-3334</issn><issn>1460-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEFP3DAQhS1URLfAnUslH6resoztOI6P1UJLJbRwAAlxsRxnIgxxTO0sYv99s8pqTyPN-97ozSPkgsGSgRaXzibnh0umlnrJgesjsmBlBQVnNXwhC2ClKIQQ5VfyLedXAFYJqU_ISV3zUgq2IGa1HaN7STEgvS8l0ICjbWLvHW3R9m_b3o4-DjR2dPAD0nUx-DHFHFs_q2HaZtps6csm2IH2_gMTDd7tmID5jBx3ts94vp-n5PH39cPqpri9-_N39eu2cELzsRAVh2YKrblqSzXlRFGiVIgWhLQd1sArq9u6cdYx1mjUiFxWyvGqdMCdOCU_57vvKf7bYB5N8Nlh39sB4yYbJmuuoFYTCDO4S5gTduY9-WDT1jAwu07N3Klhymiz63SyfN_f3jQB24NhX-Kk_9jrNjvbd8kOzucDJqa_JIgJK2bM5xE_D7JNb6ZSQklz8_Rs1vL-av18pY0U_wGWJpAw</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>Bellec, Gwénaëlle</creator><creator>Dréano, Yvonne</creator><creator>Lozach, Patrick</creator><creator>Ménez, Jean François</creator><creator>Berthou, François</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19960901</creationdate><title>Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes</title><author>Bellec, Gwénaëlle ; Dréano, Yvonne ; Lozach, Patrick ; Ménez, Jean François ; Berthou, François</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-3620b218927d47001e34e57eea035afe8026a9d8bcac11b9e9ee2567c264c02c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Aryl Hydrocarbon Hydroxylases</topic><topic>Biological and medical sciences</topic><topic>Biotransformation</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Chemical agents</topic><topic>Cytochrome P-450 CYP2A6</topic><topic>Cytochrome P-450 CYP2C19</topic><topic>Cytochrome P-450 CYP2D6 - metabolism</topic><topic>Cytochrome P-450 CYP2E1 - metabolism</topic><topic>Cytochrome P-450 CYP3A</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microsomes, Liver - enzymology</topic><topic>Mixed Function Oxygenases - metabolism</topic><topic>Nitrosamines - metabolism</topic><topic>Recombinant Proteins - metabolism</topic><topic>Substrate Specificity</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bellec, Gwénaëlle</creatorcontrib><creatorcontrib>Dréano, Yvonne</creatorcontrib><creatorcontrib>Lozach, Patrick</creatorcontrib><creatorcontrib>Ménez, Jean François</creatorcontrib><creatorcontrib>Berthou, François</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Carcinogenesis (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bellec, Gwénaëlle</au><au>Dréano, Yvonne</au><au>Lozach, Patrick</au><au>Ménez, Jean François</au><au>Berthou, François</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes</atitle><jtitle>Carcinogenesis (New York)</jtitle><addtitle>Carcinogenesis</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>17</volume><issue>9</issue><spage>2029</spage><epage>2034</epage><pages>2029-2034</pages><issn>0143-3334</issn><eissn>1460-2180</eissn><coden>CRNGDP</coden><abstract>The metabolic dealkylation of nine nitrosodialkylamines, including five symmetrical (nitrosodimethylamine, nitroso-diethylamine, nitrosodipropylamine, nitrosodibutylamine and nitrosodiamylamine) and four asymmetrical nitro-sodialkylamines (nitrosomethylethylamine, nitrosomethyl-propylamine, nitrosomethylbutylamine and nitrosomethyl-amylamine), was investigated in 14 samples of human liver microsomes. All these nitrosodialkylamines were dealkylated to aldehydes that were separated by reversed phase HPLC and UV detected as dinitrophenylhydrazones. As the length of the alkyl chain increased from methyl to pentyl, dealkylation of symmetrical nitrosodialkylamines became less efficiently catalyzed by cytochrome P450. Conversely, oxidation of the methyl moiety of asymmetrical nitrosomethylalkylamines increased with the size of the alkyl moiety, while dealkylation of the longer alkyl group decreased. N-Dealkylase activities were significantly correlated with P450 activities measured in human liver micro-somes. These catalytic activities involve CYP2A6 (coumarin 7-hydroxylation), CYP2C (mephenytoin 4-hydroxylation and tolbutamide hydroxylation), CYP2D6 (dextromethor-phan O-demethylation), CYP2E1 (chlorzoxazone and p-nitrophenol hydroxylation) and CYP3A4 (nifedipine oxidation). By using 10 heterologously expressed P450s, it was shown that nitrosodimethylamine was mainly demethylated by CYP2E1. However, such enzyme specificity was lost with increasing size of the alkyl group. Therefore, the chain length of the alkyl group of nitrosodialkylamines determined the P450 involved in its oxidation. All these results emphasize that the catalytic site of P450 2E1 has a geometric configuration such that only small molecules like nitrosodimethylamine fit favorably within the putative active site of the enzyme. Furthermore, there is good evidence that P450s other than P450 2E1, such as P450 2A6, 2C8/2C9/2C19 and 3A4, are involved in the metabolism of nitrosodialkylamines bearing bulky alkyl chains.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>8824531</pmid><doi>10.1093/carcin/17.9.2029</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0143-3334
ispartof Carcinogenesis (New York), 1996-09, Vol.17 (9), p.2029-2034
issn 0143-3334
1460-2180
language eng
recordid cdi_proquest_miscellaneous_15827087
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Aryl Hydrocarbon Hydroxylases
Biological and medical sciences
Biotransformation
Carcinogenesis, carcinogens and anticarcinogens
Chemical agents
Cytochrome P-450 CYP2A6
Cytochrome P-450 CYP2C19
Cytochrome P-450 CYP2D6 - metabolism
Cytochrome P-450 CYP2E1 - metabolism
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System - metabolism
Female
Humans
Kinetics
Male
Medical sciences
Microsomes, Liver - enzymology
Mixed Function Oxygenases - metabolism
Nitrosamines - metabolism
Recombinant Proteins - metabolism
Substrate Specificity
Tumors
title Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T05%3A05%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytochrome%20P450%20metabolic%20dealkylation%20of%20nine%20N-nitrosodialkylamines%20by%20human%20liver%20microsomes&rft.jtitle=Carcinogenesis%20(New%20York)&rft.au=Bellec,%20Gw%C3%A9na%C3%ABlle&rft.date=1996-09-01&rft.volume=17&rft.issue=9&rft.spage=2029&rft.epage=2034&rft.pages=2029-2034&rft.issn=0143-3334&rft.eissn=1460-2180&rft.coden=CRNGDP&rft_id=info:doi/10.1093/carcin/17.9.2029&rft_dat=%3Cproquest_cross%3E15827087%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15827087&rft_id=info:pmid/8824531&rfr_iscdi=true